Results for tag: "Ongentys"

Ongentys is a market within the context of Central Nervous System (CNS) drugs. CNS drugs are used to treat a variety of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, depression, and schizophrenia. Ongentys is a type of CNS drug that is used to treat Parkinson's disease. It is a monoamine oxidase type B (MAO-B) inhibitor, which works by blocking the breakdown of dopamine in the brain. This helps to improve motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and difficulty walking. Some companies in the Ongentys market include Pfizer, Merck, and Lundbeck. Pfizer is a global pharmaceutical company that produces a variety of drugs, including Ongentys. Merck is a research-driven pharmaceutical company that produces a range of drugs, including Ongentys. Lundbeck is a Danish pharmaceutical company that specializes in CNS drugs, including Ongentys. Show Less Read more